Lloyd Inc. Recalls Levothroid Tablets Due to cGMP Deviations
Lloyd Inc. of Iowa is recalling Levothroid tablets due to cGMP deviations and insufficient stability data. The recall affects 12,156 bottles distributed nationwide and to Puerto Rico.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the source text does not report any illnesses, injuries, or hospitalizations. The hazard is theoretical based on cGMP deviations and insufficient stability data, fitting the criteria for a moderate severity score.
Plain-English summary
Lloyd Inc. of Iowa is recalling 12,156 bottles of Levothroid (levothyroxine sodium tablets, USP), 88 mcg, RX only. The product was manufactured for Forest Pharmaceuticals, Inc., and repackaged by Forest Laboratories, Inc. The recall is due to current Good Manufacturing Practice (cGMP) deviations and insufficient data to determine that other lots are not affected following stability failures in previous lots.
The affected product is identified by Lot # 1098967 and has an expiration date of Mar-13. The product was distributed to 75 customers nationwide and in Puerto Rico. Consumers and healthcare providers should stop using the recalled product and contact their healthcare provider or pharmacist for guidance on alternative treatment.
The recalled product
- Product
- Levothroid (levothyroxine sodium tablets, USP), 88 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals, Inc, St. Louis, MO by Lloyd Pharmaceutical, Shenandoah, IA, NDC 0456-1329-01
- Manufacturer
- Lloyd Inc. of Iowa
- Category
- Drug — Thyroid Hormone
- Affected units
- 12,156
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 1098967
- Exp. Mar-13.
Distribution
Part of a larger recall action
This product is one of 20 recalled by Lloyd Inc. of Iowa under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 20 products in this recall →Related recalls
Same manufacturer · Lloyd Inc. of Iowa
See all →- ModerateLloyd Inc. Recalls Thyro-Tab Tablets Due to cGMP Deviations
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Levothroid Tablets Due to Quality Deviations
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Thyro-Tab Tablets Due to Quality Control Deviations
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Levothroid Tablets Due to Stability Failures
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Thyro-Tab Tablets Due to Quality Deviations
FDA (Drugs) · 2013-05-29
Same hazard · cGMP deviation
See all →- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding Limits
FDA (Drugs) · 2026-07-08
- SevereCinacalcet Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2026-07-08
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06
- ModerateIndomethacin Extended-Release Capsules recalled for cGMP deviations
FDA (Drugs) · 2025-06-11
- SevereLubricant Eye Drops Solution recalled due to sterility assurance concerns
FDA (Drugs) · 2025-05-14